Investors
Corporate Profile
At Bellerophon Therapeutics, we aim to transform the lives of people suffering from cardiopulmonary diseases by developing innovative therapies at the intersection of drugs and devices for these therapeutic areas and to do so while serving the best interests of our shareholders.
We are currently developing three product candidates under our INOpulse pro... more >
Recent News
Stock Quote
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Presentations
-
ATS 2020 PH-ILD Poster
ATS 2020 PH-ILD Poster 768.3 KB -
Corporate Presentation
Corporate Presentation 2.4 MB -
COVID 19 Overview
COVID 19 Overview 1.2 MB -
PFF 2019 Poster - Sub-Group Analysis
PFF 2019 Poster - Sub-Group Analysis 217.3 KB -
PFF 2019 Poster - Actigrpahy Endpoint
-
American College of Chest Physicians Conference Presentation
-
KOL Day Presentation
KOL Day Presentation 4 MB -
ATS 2019 PH-ILD Poster
ATS 2019 PH-ILD Poster 310.5 KB -
2019 ATS PH-ILD Presentation
2019 ATS PH-ILD Presentation 452.8 KB -
2019 PVRI Poster – iNO DDI Study
2019 PVRI Poster – iNO DDI Study 339.9 KB -
2019 PVRI Poster – Actigraphy in PH-PF
-
Key Opinion Leader Lunch : Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD) with Dr. Steve Nathan
-
2017 ATS Poster - PH-IPF
2017 ATS Poster - PH-IPF 2.2 MB -
2017 ATS Poster - PH-COPD
-
2017 ISHLT Poster
2017 ISHLT Poster 417.9 KB -
2016 ATS Poster
2016 ATS Poster 971 KB -
2015 PHPN Poster
2015 PHPN Poster 684.5 KB
Data Provided by Refinitiv. Minimum 15 minutes delayed.